Is Modine (MOD) a Buy as Wall Street Analysts Look Optimistic? — Positive

MOD   Zacks Investment Research — January 13, 2026

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Is Modine (MOD) a Buy as Wall Street Analysts Look Optimistic?

Wall Street Bulls Look Optimistic About Gold.com (GOLD): Should You Buy? — Positive

GOLD   Zacks Investment Research — January 13, 2026

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Wall Street Bulls Look Optimistic About Gold.com (GOLD): Should You Buy?

Is SharkNinja, Inc. (SN) a Buy as Wall Street Analysts Look Optimistic? — Positive

SN   Zacks Investment Research — January 13, 2026

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Is SharkNinja, Inc. (SN) a Buy as Wall Street Analysts Look Optimistic?

Nice (NICE) Is Considered a Good Investment by Brokers: Is That True? — Positive

NICE   Zacks Investment Research — January 13, 2026

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Nice (NICE) Is Considered a Good Investment by Brokers: Is That True?

Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? — Positive

ADMA   Zacks Investment Research — January 13, 2026

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?

Why Planet Labs Jumped 12% Yesterday — Positive

PL   Forbes — January 13, 2026

Planet Labs (PL) climbed +12% on January 12, 2026, in response to the announcement of a multi-year, low nine-figure agreement with the Swedish Armed Forces. The stock gapped up on substantial volume, breaking through recent resistance.

image for news Why Planet Labs Jumped 12% Yesterday

While Intel's stock has booked nice gains over the last year, those largely don't relate to artificial-intelligence prowess. A KeyBanc analyst thinks that could be changing.

image for news Intel's stock is popping. Here's how it can become an AI winner and rack up even more gains.

Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains? — Positive

DAWN   Zacks Investment Research — January 13, 2026

Day One Biopharmaceuticals (DAWN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

image for news Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?

Reasons Why You Should Retain FTI Consulting Stock in Your Portfolio — Positive

FCN   Zacks Investment Research — January 13, 2026

FCN shares beat industry gains as diversified consulting, solid liquidity and ongoing buybacks indicate modest earnings growth in 2026.

image for news Reasons Why You Should Retain FTI Consulting Stock in Your Portfolio

Ernest Hoffman is a Crypto and Market Reporter for Kitco News. He has over 15 years of experience as a writer, editor, broadcaster and producer for media, educational and cultural organizations.

image for news Spot gold above $4,620/oz after U.S. new home sales rise 3.8% in September, fall 0.1% in October

Best Growth Stocks to Buy in 2026 — Positive

AVGO  GOOG  GOOGL  MELI   24/7 Wall Street — January 13, 2026

2026 is on a fresh start, and January is nearly halfway over. While we cannot slow the hands of time, we can look at it as an opportunity to make money.

image for news Best Growth Stocks to Buy in 2026

Why The Recent Drop In Centrus Is A Gift For Investors — Positive

LEU   Seeking Alpha — January 13, 2026

I'm upgrading Centrus Energy (LEU) to Buy, which is reflective of the improved valuation and strategic progress in HALEU enrichment. LEU's unique position as the only U.S. HALEU producer aligns with surging demand from next-generation nuclear reactors. A $900 million DOE grant and multi-billion dollar expansion in Piketon, Ohio, strengthen LEU's growth trajectory.

image for news Why The Recent Drop In Centrus Is A Gift For Investors

Microsoft on Tuesday released details of a new plan attempting to alleviate concerns from consumers around their massive push to build new AI data centers, including pledge to pay higher electricity fees and minimize water use, echoing President Donald Trump who has made affordability a top concern as inflation—and utility costs—have surged.

image for news Microsoft Promises Limit On Data Center Electricity Costs—Following Trump Pledge

Abercrombie Down More Than 17% on Revised View, Issues Business Update — Negative

ANF   Zacks Investment Research — January 13, 2026

ANF slides more than17% as updated Q4 and fiscal 2025 forecasts factored in tariffs, trimming sales growth and margin outlook despite solid demand.

image for news Abercrombie Down More Than 17% on Revised View, Issues Business Update

Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes — Positive

SNY   Zacks Investment Research — January 13, 2026

SNY wins EU approval for Teizeild, the first disease-modifying drug to delay stage 3 type 1 diabetes in adults and children aged eight and older.

image for news Sanofi's Teizeild Gets EU Approval for Treating Type 1 Diabetes

Innovative Industrial: Buying The 9.7% Yielding Preferreds — Positive

IIPR   Seeking Alpha — January 13, 2026

Innovative Industrial Properties (IIPR) has not cut its dividend despite significant tenant defaults and a 15% YoY revenue decline. IIPR's 2026 bonds have performed well. Tenant receiverships are ongoing, but strong property interest and potential cannabis rescheduling could materially improve tenant credit quality and rent coverage.

image for news Innovative Industrial: Buying The 9.7% Yielding Preferreds

Hegseth Visits Lockheed Martin to Push Trump's Defense Budget — Positive

LMT   Bloomberg Markets and Finance — January 13, 2026

image for news Hegseth Visits Lockheed Martin to Push Trump's Defense Budget

Enphase Starts US Shipments of IQ9 Commercial Microinverters — Neutral

ENPH   Zacks Investment Research — January 13, 2026

ENPH begins U.S. shipments of its first GaN-based IQ9N-3P commercial microinverter, built domestically to meet compliance needs.

image for news Enphase Starts US Shipments of IQ9 Commercial Microinverters

Seagate's 32TB HDDs Launch Expands Its Reach in AI Video Analytics — Positive

STX   Zacks Investment Research — January 13, 2026

STX rolls out 32TB HDDs across Exos, SkyHawk AI and IronWolf Pro, targeting edge-to-cloud AI video analytics and rising data demands.

image for news Seagate's 32TB HDDs Launch Expands Its Reach in AI Video Analytics

AAR Corp. (AIR) Hits Fresh High: Is There Still Room to Run? — Positive

AIR   Zacks Investment Research — January 13, 2026

AAR (AIR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

image for news AAR Corp. (AIR) Hits Fresh High: Is There Still Room to Run?